EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Therapeutic effect of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium in cerebral palsy model

Eun-Jung Yoon, Jiwon Jeong, Yunseo Choi, Dae Hwan Kim, Tae Myoung Kim, Ehn-Kyoung Choi, Yun-Bae Kim, Dongsun Park iD

Stem Cells Translational Medicine · 2026

DOI: 10.1093/stcltm/szaf071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Eun-Jung Yoon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University, Chuncheon-si 24341, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Cerebral Palsy, Mesenchymal Stem Cells, Amnion. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cerebral palsy (CP), primarily caused by perinatal cerebral hypoxia and ischemia, is a devastating neurological disease in children characterized by motor, behavioral, and cognitive disorders. This study aimed to evaluate the therapeutic effects of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium (ERCM) in a CP model.

Methods

ERCM components were analyzed using enzyme-linked immunosorbent assay. Biodistribution was examined via fluorescence-labeled ERCM in both normal and CP induced animals. In vitro, the neuroprotective effects of ERCM against lipopolysaccharide and potassium cyanide-induced cytotoxicity were assessed in human neural stem cells and oligodendrocyte progenitor cells, focusing on apoptosis, inflammation, and oligodendrocyte differentiation. In vivo, ERCM was injected into CP-induced animals, followed by evaluation of antiapoptotic and anti-inflammatory signaling, motor and cognitive function, and white matter integrity.

Results

ERCM contained a broad array of growth factors and demonstrated enhanced retention in CP-affected brain regions. In vitro, ERCM significantly reduced apoptos is and inflammation, and promoted oligodendrocyte maturation via upregulation of Nkx2.2, CN Pase, and MBP. In vivo, ERCM treatment improved motor and cognitive performance, in hibited cell death and inflammatory responses, and increased expression of oligodendrocyte markers, including Nkx2.2, Olig2, CNPase, and MBP via increasing growth factor expression. Furthermore, ERCM attenuated demyelination in the corpus callosum, a region particularly vulnerable in CP.

Conclusion

ERCM confers therapeutic benefits in CP by preserving neural stem and oligodendrocyte progenitor cells, modulating apoptosis and inflammation, and enhancing oligodendrocyte differentiation. Accordingly, ERCM may present a good candidate as a CP therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCerebral PalsyMesenchymal Stem CellsAmnionAnimalsCulture Media, ConditionedHumansDisease Models, AnimalCell DifferentiationApoptosisRatsNeural Stem CellsOligodendrogliaRats, Sprague-Dawley

Stichwörter der Autor:innen

AMMSCcerebral palsyexosomegrowth factorneural stem cellsoligodendrocyte

Substanzen

Culture Media, Conditioned

Autor:innen und Institutionen

  • Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Kangwon National University, Chuncheon-si 24341, Republic of Korea.
  • Department of Life Sports Educator, Kongju National University, Kongju 32588, Republic of Korea.
  • Platform Technology Group, Prestige Biopharma IDC, Busan 46726, Republic of Korea.
  • Central Research Institute, Designed Cells Co., Ltd, Cheongju 28576, Republic of Korea.
  • Laboratory of Veterinary Toxicology, College of Veterinary Medicine, Chungbuk National University, Cheongju-si 28644, Republic of Korea.

ORCID-Profile: Dongsun Park

Förderung

  • Ministry of Education

Zitieren

APA

Yoon, E. J., Jeong, J., Choi, Y., Kim, D. H., Kim, T. M., Choi, E. K., Kim, Y. B., & Park, D. (2026). Therapeutic effect of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium in cerebral palsy model. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf071

Vancouver

Yoon EJ, Jeong J, Choi Y, Kim DH, Kim TM, Choi EK, et al. Therapeutic effect of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium in cerebral palsy model. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szaf071

BibTeX
@article{Yoon2026,
  author = {Yoon, Eun-Jung and Jeong, Jiwon and Choi, Yunseo and Kim, Dae Hwan and Kim, Tae Myoung and Choi, Ehn-Kyoung and Kim, Yun-Bae and Park, Dongsun},
  title = {Therapeutic effect of amniotic membrane mesenchymal stem cell-derived exosome-rich conditioned medium in cerebral palsy model},
  journal = {Stem Cells Translational Medicine},
  year = {2026},
  doi = {10.1093/stcltm/szaf071}
}
Kostenlos starten →